{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:46:28Z","timestamp":1793810788588,"version":"4.6.1"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103460"],"award-info":[{"award-number":["82103460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00204-023-03653-7","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T12:02:16Z","timestamp":1703764936000},"page":"689-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Medication-related osteonecrosis\u2002of the\u2002jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies"],"prefix":"10.1007","volume":"98","author":[{"given":"Aiming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"8","key":"3653_CR1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jbmr.379","volume":"26","author":"TL Aghaloo","year":"2011","unstructured":"Aghaloo TL, Kang B, Sung EC et al (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26(8):1871\u20131882. https:\/\/doi.org\/10.1002\/jbmr.379","journal-title":"J Bone Miner Res"},{"key":"3653_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116168","volume":"153","author":"JI Aguirre","year":"2021","unstructured":"Aguirre JI, Castillo EJ, Kimmel DB (2021a) Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ). Bone 153:116168. https:\/\/doi.org\/10.1016\/j.bone.2021.116168","journal-title":"Bone"},{"key":"3653_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116184","volume":"153","author":"JI Aguirre","year":"2021","unstructured":"Aguirre JI, Castillo EJ, Kimmel DB (2021b) Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone 153:116184. https:\/\/doi.org\/10.1016\/j.bone.2021.116184","journal-title":"Bone"},{"issue":"2","key":"3653_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000313787","volume":"124","author":"A Allegra","year":"2010","unstructured":"Allegra A, Alonci A, Penna G et al (2010) Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws. Acta Haematol 124(2):79\u201385. https:\/\/doi.org\/10.1159\/000313787","journal-title":"Acta Haematol"},{"issue":"5","key":"3653_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","volume":"66","author":"MR Allen","year":"2008","unstructured":"Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66(5):987\u2013994. https:\/\/doi.org\/10.1016\/j.joms.2008.01.038","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"3653_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-019-05265-1","volume":"176","author":"AA Awan","year":"2019","unstructured":"Awan AA, Hutton B, Hilton J et al (2019) De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 176(3):507\u2013517. https:\/\/doi.org\/10.1007\/s10549-019-05265-1","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3653_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1021\/acs.jmedchem.0c01292","volume":"64","author":"JS Barbosa","year":"2021","unstructured":"Barbosa JS, Almeida Paz FA, Braga SS (2021) Bisphosphonates, old friends of bones and new trends in clinics. J Med Chem 64(3):1260\u20131282. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01292","journal-title":"J Med Chem"},{"issue":"25","key":"3653_CR8","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","volume":"363","author":"JD Bashutski","year":"2010","unstructured":"Bashutski JD, Eber RM, Kinney JS et al (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363(25):2396\u20132405. https:\/\/doi.org\/10.1056\/NEJMoa1005361","journal-title":"N Engl J Med"},{"issue":"3","key":"3653_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","volume":"105","author":"A Bedogni","year":"2008","unstructured":"Bedogni A, Blandamura S, Lokmic Z et al (2008) Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(3):358\u2013364. https:\/\/doi.org\/10.1016\/j.tripleo.2007.08.040","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"3653_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.oraloncology.2011.02.024","volume":"47","author":"A Bedogni","year":"2011","unstructured":"Bedogni A, Saia G, Bettini G et al (2011) Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 47(5):420\u2013424. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.02.024","journal-title":"Oral Oncol"},{"issue":"1","key":"3653_CR11","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.4317\/jced.53372","volume":"9","author":"EB Berm\u00fadez-Bejarano","year":"2017","unstructured":"Berm\u00fadez-Bejarano EB, Serrera-Figallo M, Guti\u00e9rrez-Corrales A et al (2017) Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent 9(1):e141\u2013e149. https:\/\/doi.org\/10.4317\/jced.53372","journal-title":"J Clin Exp Dent"},{"issue":"2","key":"3653_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","volume":"104","author":"SD Bianchi","year":"2007","unstructured":"Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M (2007) Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(2):249\u2013258. https:\/\/doi.org\/10.1016\/j.tripleo.2007.01.040","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"3653_CR13","first-page":"144","volume":"7","author":"O Bock","year":"2007","unstructured":"Bock O, Boerst H, Thomasius FE et al (2007) Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. J Musculoskelet Neuronal Interact 7(2):144\u2013148","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"8322","key":"3653_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0140-6736(83)91465-4","volume":"1","author":"HM Bounameaux","year":"1983","unstructured":"Bounameaux HM, Schifferli J, Montani JP, Jung A, Chatelanat F (1983) Renal failure associated with intravenous diphosphonates. Lancet 1(8322):471. https:\/\/doi.org\/10.1016\/s0140-6736(83)91465-4","journal-title":"Lancet"},{"issue":"4","key":"3653_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4065\/mcp.2009.0492","volume":"85","author":"L Caplan","year":"2010","unstructured":"Caplan L, Pittman CB, Zeringue AL et al (2010) An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy. Mayo Clin Proc 85(4):341\u2013348. https:\/\/doi.org\/10.4065\/mcp.2009.0492","journal-title":"Mayo Clin Proc"},{"issue":"5 Suppl","key":"3653_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):85\u201395. https:\/\/doi.org\/10.1016\/j.joms.2009.01.006","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"3653_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/0022034513518561","volume":"93","author":"AC Carreira","year":"2014","unstructured":"Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM (2014) Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res 93(4):335\u2013345. https:\/\/doi.org\/10.1177\/0022034513518561","journal-title":"J Dent Res"},{"key":"3653_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.878556","volume":"13","author":"KY Chin","year":"2022","unstructured":"Chin KY, Ekeuku SO, Trias A (2022) The role of geranylgeraniol in managing bisphosphonate-related osteonecrosis of the jaw. Front Pharmacol 13:878556. https:\/\/doi.org\/10.3389\/fphar.2022.878556","journal-title":"Front Pharmacol"},{"issue":"2","key":"3653_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/sctm.19-0092","volume":"9","author":"L Chow","year":"2020","unstructured":"Chow L, Johnson V, Impastato R, Coy J, Strumpf A, Dow S (2020) Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells. Stem Cells Transl Med 9(2):235\u2013249. https:\/\/doi.org\/10.1002\/sctm.19-0092","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"3653_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/SCS.0b013e31824dbdd4","volume":"23","author":"M Cicci\u00f9","year":"2012","unstructured":"Cicci\u00f9 M, Herford AS, Juod\u017ebalys G, Stoffella E (2012) Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw. J Craniofac Surg 23(3):784\u2013788. https:\/\/doi.org\/10.1097\/SCS.0b013e31824dbdd4","journal-title":"J Craniofac Surg"},{"issue":"3","key":"3653_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin P, Coleman R, Puppo M et al (2021) Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev 101(3):797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019","journal-title":"Physiol Rev"},{"key":"3653_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1749-6632.2010.05766.x","volume":"1218","author":"R Coleman","year":"2011","unstructured":"Coleman R (2011) The use of bisphosphonates in cancer treatment. Ann N Y Acad Sci 1218:3\u201314. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05766.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3653_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1359\/jbmr.090704","volume":"25","author":"CS Col\u00f3n-Emeric","year":"2010","unstructured":"Col\u00f3n-Emeric CS, Mesenbrink P, Lyles KW et al (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25(1):91\u201397. https:\/\/doi.org\/10.1359\/jbmr.090704","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3653_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00784-020-03551-7","volume":"25","author":"VC de Sousa Ferreira","year":"2021","unstructured":"de Sousa Ferreira VC, Lopes AP, Alves NM et al (2021) Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling. Clin Oral Investig 25(2):673\u2013682. https:\/\/doi.org\/10.1007\/s00784-020-03551-7","journal-title":"Clin Oral Investig"},{"key":"3653_CR25","doi-asserted-by":"publisher","first-page":"2684924","DOI":"10.1155\/2018\/2684924","volume":"2018","author":"O Di Fede","year":"2018","unstructured":"Di Fede O, Panzarella V, Mauceri R et al (2018) The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. Biomed Res Int 2018:2684924. https:\/\/doi.org\/10.1155\/2018\/2684924","journal-title":"Biomed Res Int"},{"issue":"9","key":"3653_CR26","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032\u20131045. https:\/\/doi.org\/10.4065\/83.9.1032","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"3653_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M et al (2019) Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 30(5):706\u2013720. https:\/\/doi.org\/10.1093\/annonc\/mdz056","journal-title":"Ann Oncol"},{"issue":"1","key":"3653_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/br201301003","volume":"1","author":"X Feng","year":"2013","unstructured":"Feng X, Teitelbaum SL (2013) Osteoclasts: new insights. Bone Res 1(1):11\u201326. https:\/\/doi.org\/10.4248\/br201301003","journal-title":"Bone Res"},{"issue":"3","key":"3653_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5978\/islsm.17-CR-04","volume":"26","author":"C Fornaini","year":"2017","unstructured":"Fornaini C, Cella L, Oppici A et al (2017) Laser and platelet-rich plasma to treat medication-related osteonecrosis of the jaws (MRONJ): a case report. Laser Ther 26(3):223\u2013227. https:\/\/doi.org\/10.5978\/islsm.17-CR-04","journal-title":"Laser Ther"},{"issue":"8","key":"3653_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0022034518759302","volume":"97","author":"CF Francisconi","year":"2018","unstructured":"Francisconi CF, Vieira AE, Azevedo MCS et al (2018) RANKL triggers treg-mediated immunoregulation in inflammatory osteolysis. J Dent Res 97(8):917\u2013927. https:\/\/doi.org\/10.1177\/0022034518759302","journal-title":"J Dent Res"},{"issue":"4","key":"3653_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","volume":"118","author":"E Franco-Pretto","year":"2014","unstructured":"Franco-Pretto E, Pacheco M, Moreno A, Messa O, Gnecco J (2014) Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings. Oral Surg Oral Med Oral Pathol Oral Radiol 118(4):408\u2013417. https:\/\/doi.org\/10.1016\/j.oooo.2014.04.017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"3653_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0002-9394(02)01840-8","volume":"135","author":"FW Fraunfelder","year":"2003","unstructured":"Fraunfelder FW, Fraunfelder FT, Jensvold B (2003) Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol 135(2):219\u2013222. https:\/\/doi.org\/10.1016\/s0002-9394(02)01840-8","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3653_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/IAE.0b013e31816576ef","volume":"28","author":"DD French","year":"2008","unstructured":"French DD, Margo CE (2008) Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 28(6):889\u2013893. https:\/\/doi.org\/10.1097\/IAE.0b013e31816576ef","journal-title":"Retina"},{"key":"3653_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/tcrm.S35788","volume":"9","author":"D Gatti","year":"2013","unstructured":"Gatti D, Rossini M, Viapiana O, Idolazzi L, Adami S (2013) Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag 9:139\u2013147. https:\/\/doi.org\/10.2147\/tcrm.S35788","journal-title":"Ther Clin Risk Manag"},{"key":"3653_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063112","author":"YC Gau","year":"2022","unstructured":"Gau YC, Yeh TJ, Hsu CM, Hsiao SY, Hsiao HH (2022) Pathogenesis and treatment of myeloma-related bone disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23063112","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3653_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"A Giusti","year":"2010","unstructured":"Giusti A, Hamdy NA, Papapoulos SE (2010) Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47(2):169\u2013180. https:\/\/doi.org\/10.1016\/j.bone.2010.05.019","journal-title":"Bone"},{"key":"3653_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020330","author":"I Gkouveris","year":"2022","unstructured":"Gkouveris I, Soundia A, Gouveris P, Zouki D, Hadaya D, Tetradis S (2022) Macrophage involvement in medication-related osteonecrosis of the jaw (MRONJ): a comprehensive, short review. Cancers (basel). https:\/\/doi.org\/10.3390\/cancers14020330","journal-title":"Cancers (basel)"},{"issue":"6","key":"3653_CR38","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.26355\/eurrev_202103_25430","volume":"25","author":"F Goker","year":"2021","unstructured":"Goker F, Grecchi E, Grecchi F, Francetti L, Del Fabbro M (2021) Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review. Eur Rev Med Pharmacol Sci 25(6):2662\u20132673. https:\/\/doi.org\/10.26355\/eurrev_202103_25430","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3653_CR39","doi-asserted-by":"publisher","first-page":"36129","DOI":"10.1038\/srep36129","volume":"7","author":"X Gong","year":"2017","unstructured":"Gong X, Yu W, Zhao H, Su J, Sheng Q (2017) Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro bmscs osteogenic activity. Sci Rep 7:36129. https:\/\/doi.org\/10.1038\/srep36129","journal-title":"Sci Rep"},{"key":"3653_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115676","volume":"141","author":"D Govaerts","year":"2020","unstructured":"Govaerts D, Piccart F, Ockerman A, Coropciuc R, Politis C, Jacobs R (2020) Adjuvant therapies for MRONJ: a systematic review. Bone 141:115676. https:\/\/doi.org\/10.1016\/j.bone.2020.115676","journal-title":"Bone"},{"key":"3653_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4444","volume":"341","author":"J Green","year":"2010","unstructured":"Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V (2010) Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 341:c4444. https:\/\/doi.org\/10.1136\/bmj.c4444","journal-title":"BMJ"},{"issue":"11","key":"3653_CR42","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.joms.2018.05.025","volume":"76","author":"D Hadaya","year":"2018","unstructured":"Hadaya D, Soundia A, Freymiller E et al (2018) Nonsurgical management of medication-related osteonecrosis of the jaws using local wound care. J Oral Maxillofac Surg 76(11):2332\u20132339. https:\/\/doi.org\/10.1016\/j.joms.2018.05.025","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"3653_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.joms.2018.08.010","volume":"77","author":"D Hadaya","year":"2019","unstructured":"Hadaya D, Soundia A, Gkouveris I, Dry SM, Aghaloo TL, Tetradis S (2019) Development of medication-related osteonecrosis of the jaw after extraction of teeth with experimental periapical disease. J Oral Maxillofac Surg 77(1):71\u201386. https:\/\/doi.org\/10.1016\/j.joms.2018.08.010","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"3653_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00784-014-1219-0","volume":"19","author":"N Hagelauer","year":"2015","unstructured":"Hagelauer N, Pabst AM, Ziebart T, Ulbrich H, Walter C (2015) In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes. Clin Oral Investig 19(1):139\u2013148. https:\/\/doi.org\/10.1007\/s00784-014-1219-0","journal-title":"Clin Oral Investig"},{"issue":"6","key":"3653_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s8756-3282(01)00615-9","volume":"29","author":"JM Halasy-Nagy","year":"2001","unstructured":"Halasy-Nagy JM, Rodan GA, Reszka AA (2001) Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29(6):553\u2013559. https:\/\/doi.org\/10.1016\/s8756-3282(01)00615-9","journal-title":"Bone"},{"issue":"4","key":"3653_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.oooo.2016.11.011","volume":"123","author":"F Hallmer","year":"2017","unstructured":"Hallmer F, Bj\u00f8rnland T, Andersson G, Becktor JP, Kristoffersen AK, Enersen M (2017) Bacterial diversity in medication-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 123(4):436\u2013444. https:\/\/doi.org\/10.1016\/j.oooo.2016.11.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"3653_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","volume":"30","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa T, Hayashida S, Kondo E et al (2019) Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study. Osteoporos Int 30(1):231\u2013239. https:\/\/doi.org\/10.1007\/s00198-018-4746-8","journal-title":"Osteoporos Int"},{"issue":"3","key":"3653_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2010) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14(3):271\u2013284. https:\/\/doi.org\/10.1007\/s00784-009-0300-6","journal-title":"Clin Oral Investig"},{"issue":"12","key":"3653_CR49","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1002\/dvdy.21781","volume":"237","author":"D Hu","year":"2008","unstructured":"Hu D, Colnot C, Marcucio RS (2008) Effect of bone morphogenetic protein signaling on development of the jaw skeleton. Dev Dyn 237(12):3727\u20133737. https:\/\/doi.org\/10.1002\/dvdy.21781","journal-title":"Dev Dyn"},{"issue":"9","key":"3653_CR50","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1248\/yakushi.132.1025","volume":"132","author":"K Iguchi","year":"2012","unstructured":"Iguchi K (2012) Effect of bisphosphonates on anticancer activity in prostate cancer cells. Yakugaku Zasshi 132(9):1025\u20131030. https:\/\/doi.org\/10.1248\/yakushi.132.1025","journal-title":"Yakugaku Zasshi"},{"issue":"18","key":"3653_CR51","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","volume":"25","author":"GI Im","year":"2004","unstructured":"Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25(18):4105\u20134115. https:\/\/doi.org\/10.1016\/j.biomaterials.2003.11.024","journal-title":"Biomaterials"},{"issue":"1","key":"3653_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2003.08.011","volume":"477","author":"F Itoh","year":"2003","unstructured":"Itoh F, Aoyagi S, Furihata-Komatsu H et al (2003) Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures. Eur J Pharmacol 477(1):9\u201316. https:\/\/doi.org\/10.1016\/j.ejphar.2003.08.011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"3653_CR53","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jbmr.1769","volume":"28","author":"S Kalyan","year":"2013","unstructured":"Kalyan S, Quabius ES, Wiltfang J, M\u00f6nig H, Kabelitz D (2013) Can peripheral blood \u03b3\u03b4 T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy. J Bone Miner Res 28(4):728\u2013735. https:\/\/doi.org\/10.1002\/jbmr.1769","journal-title":"J Bone Miner Res"},{"key":"3653_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-018-0074-9","volume":"38","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Okinaga T, Hikiji H et al (2018) Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen 38:16. https:\/\/doi.org\/10.1186\/s41232-018-0074-9","journal-title":"Inflamm Regen"},{"issue":"7","key":"3653_CR55","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/jbmr.1894","volume":"28","author":"B Kang","year":"2013","unstructured":"Kang B, Cheong S, Chaichanasakul T et al (2013) Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res 28(7):1631\u20131640. https:\/\/doi.org\/10.1002\/jbmr.1894","journal-title":"J Bone Miner Res"},{"issue":"0 1","key":"3653_CR56","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/s0020-1383(16)30015-8","volume":"47","author":"SL Kates","year":"2016","unstructured":"Kates SL, Ackert-Bicknell CL (2016) How do bisphosphonates affect fracture healing? Injury 47(0 1):S65\u2013S68. https:\/\/doi.org\/10.1016\/s0020-1383(16)30015-8","journal-title":"Injury"},{"key":"3653_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104526","volume":"375","author":"K Kaur","year":"2022","unstructured":"Kaur K, Kanayama K, Wu QQ, Gumrukcu S, Nishimura I, Jewett A (2022) Zoledronic acid mediated differential activation of NK cells in different organs of WT and Rag2(-\/-) mice; stark differences between the bone marrow and gingivae. Cell Immunol 375:104526. https:\/\/doi.org\/10.1016\/j.cellimm.2022.104526","journal-title":"Cell Immunol"},{"issue":"1","key":"3653_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3\u201323. https:\/\/doi.org\/10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"issue":"8","key":"3653_CR59","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00784-016-1718-2","volume":"20","author":"JW Kim","year":"2016","unstructured":"Kim JW, Landayan ME, Lee JY et al (2016) Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw. Clin Oral Investig 20(8):2251\u20132258. https:\/\/doi.org\/10.1007\/s00784-016-1718-2","journal-title":"Clin Oral Investig"},{"key":"3653_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082145","author":"S Kim","year":"2022","unstructured":"Kim S, Mun S, Shin W, Han K, Kim MY (2022) Identification of potentially pathogenic variants associated with recurrence in medication-related osteonecrosis of the jaw (MRONJ) patients using whole-exome sequencing. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11082145","journal-title":"J Clin Med"},{"issue":"1","key":"3653_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jdsr.2018.12.001","volume":"55","author":"Y Kitagawa","year":"2019","unstructured":"Kitagawa Y, Ohga N, Asaka T et al (2019) Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw. Jpn Dent Sci Rev 55(1):65\u201370. https:\/\/doi.org\/10.1016\/j.jdsr.2018.12.001","journal-title":"Jpn Dent Sci Rev"},{"issue":"4","key":"3653_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.7150\/jca.15989","volume":"8","author":"AK Kozlowska","year":"2017","unstructured":"Kozlowska AK, Topchyan P, Kaur K et al (2017) Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells\/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs. J Cancer 8(4):537\u2013554. https:\/\/doi.org\/10.7150\/jca.15989","journal-title":"J Cancer"},{"issue":"11","key":"3653_CR63","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.amjmed.2018.04.028","volume":"131","author":"I Kravets","year":"2018","unstructured":"Kravets I (2018) Paget\u2019s disease of bone: diagnosis and treatment. Am J Med 131(11):1298\u20131303. https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.028","journal-title":"Am J Med"},{"issue":"2","key":"3653_CR64","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/RCT.0b013e31817e4986","volume":"33","author":"A Krishnan","year":"2009","unstructured":"Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N (2009) Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings. J Comput Assist Tomogr 33(2):298\u2013304. https:\/\/doi.org\/10.1097\/RCT.0b013e31817e4986","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"3653_CR65","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1476-5381.2011.01592.x","volume":"165","author":"JW Kuiper","year":"2012","unstructured":"Kuiper JW, Forster C, Sun C, Peel S, Glogauer M (2012) Zoledronate and pamidronate depress neutrophil functions and survival in mice. Br J Pharmacol 165(2):532\u2013539. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01592.x","journal-title":"Br J Pharmacol"},{"issue":"8\u20139","key":"3653_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/dvg.23500","volume":"60","author":"S Kuroshima","year":"2022","unstructured":"Kuroshima S, Al-Omari FA, Sasaki M, Sawase T (2022) Medication-related osteonecrosis of the jaw: a literature review and update. Genesis 60(8\u20139):e23500. https:\/\/doi.org\/10.1002\/dvg.23500","journal-title":"Genesis"},{"issue":"2","key":"3653_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11138\/ccmbm\/2017.14.1.153","volume":"14","author":"PT Leali","year":"2017","unstructured":"Leali PT, Balsano M, Maestretti G et al (2017) Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study. Clin Cases Miner Bone Metab 14(2):153\u2013156. https:\/\/doi.org\/10.11138\/ccmbm\/2017.14.1.153","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"4","key":"3653_CR68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.joms.2017.09.021","volume":"76","author":"J Lemound","year":"2018","unstructured":"Lemound J, Muecke T, Zeller AN, Lichtenstein J, Eckardt A, Gellrich NC (2018) Nasolabial flap improves healing in medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 76(4):877\u2013885. https:\/\/doi.org\/10.1016\/j.joms.2017.09.021","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"3653_CR69","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2174\/0929867327666200330142432","volume":"28","author":"H Li","year":"2021","unstructured":"Li H, Xiao Z, Quarles LD, Li W (2021) Osteoporosis: mechanism, molecular target and current status on drug development. Curr Med Chem 28(8):1489\u20131507. https:\/\/doi.org\/10.2174\/0929867327666200330142432","journal-title":"Curr Med Chem"},{"issue":"1","key":"3653_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13104-021-05900-5","volume":"15","author":"JW Li","year":"2022","unstructured":"Li JW, Wang JY, Yu RQ, Huo L, Zheng LW (2022a) Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid. BMC Res Notes 15(1):12. https:\/\/doi.org\/10.1186\/s13104-021-05900-5","journal-title":"BMC Res Notes"},{"issue":"4","key":"3653_CR71","doi-asserted-by":"publisher","first-page":"9741","DOI":"10.1080\/21655979.2022.2060584","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Xu R, Ye JX, Yuan FL (2022b) Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p. Bioengineered 13(4):9741\u20139753. https:\/\/doi.org\/10.1080\/21655979.2022.2060584","journal-title":"Bioengineered"},{"issue":"2","key":"3653_CR72","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/wrr.12398","volume":"24","author":"MK Lichtman","year":"2016","unstructured":"Lichtman MK, Otero-Vinas M, Falanga V (2016) Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis. Wound Repair Regen 24(2):215\u2013222. https:\/\/doi.org\/10.1111\/wrr.12398","journal-title":"Wound Repair Regen"},{"key":"3653_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/298945","volume":"2014","author":"F Longo","year":"2014","unstructured":"Longo F, Guida A, Aversa C et al (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945. https:\/\/doi.org\/10.1155\/2014\/298945","journal-title":"Int J Dent"},{"issue":"8","key":"3653_CR74","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","volume":"44","author":"P Lopez-Jornet","year":"2016","unstructured":"Lopez-Jornet P, Sanchez Perez A, Amaral Mendes R, Tobias A (2016) Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review. J Craniomaxillofac Surg 44(8):1067\u20131072. https:\/\/doi.org\/10.1016\/j.jcms.2016.05.004","journal-title":"J Craniomaxillofac Surg"},{"issue":"8","key":"3653_CR75","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/jbm.a.36944","volume":"108","author":"EM Lotz","year":"2020","unstructured":"Lotz EM, Lohmann CH, Boyan BD, Schwartz Z (2020) Bisphosphonates inhibit surface-mediated osteogenesis. J Biomed Mater Res A 108(8):1774\u20131786. https:\/\/doi.org\/10.1002\/jbm.a.36944","journal-title":"J Biomed Mater Res A"},{"issue":"4","key":"3653_CR76","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/eje-20-0299","volume":"183","author":"R Marom","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R (2020) Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 183(4):R95-r106. https:\/\/doi.org\/10.1530\/eje-20-0299","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"3653_CR77","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","volume":"68","author":"N Maruotti","year":"2012","unstructured":"Maruotti N, Corrado A, Neve A, Cantatore FP (2012) Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol 68(7):1013\u20131018. https:\/\/doi.org\/10.1007\/s00228-012-1216-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"3653_CR78","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1359\/jbmr.2001.16.11.2050","volume":"16","author":"I Mathov","year":"2001","unstructured":"Mathov I, Plotkin LI, Sgarlata CL, Leoni J, Bellido T (2001) Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 16(11):2050\u20132056. https:\/\/doi.org\/10.1359\/jbmr.2001.16.11.2050","journal-title":"J Bone Miner Res"},{"key":"3653_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biology11091254","author":"E Mijiritsky","year":"2022","unstructured":"Mijiritsky E, Assaf HD, Kolerman R, Mangani L, Ivanova V, Zlatev S (2022) Autologous platelet concentrates (APCs) for hard tissue regeneration in oral implantology, sinus floor elevation, peri-implantitis, socket preservation, and medication-related osteonecrosis of the jaw (MRONJ): a literature review. Biology (basel). https:\/\/doi.org\/10.3390\/biology11091254","journal-title":"Biology (basel)"},{"issue":"3","key":"3653_CR80","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/bf02010363","volume":"22","author":"SC Miller","year":"1977","unstructured":"Miller SC, Jee WS, Kimmel DB, Woodbury L (1977) Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei. Calcif Tissue Res 22(3):243\u2013252. https:\/\/doi.org\/10.1007\/bf02010363","journal-title":"Calcif Tissue Res"},{"issue":"12","key":"3653_CR81","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1359\/jbmr.050817","volume":"20","author":"PD Miller","year":"2005","unstructured":"Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20(12):2105\u20132115. https:\/\/doi.org\/10.1359\/jbmr.050817","journal-title":"J Bone Miner Res"},{"key":"3653_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2723","volume":"350","author":"S Minisola","year":"2015","unstructured":"Minisola S, Pepe J, Piemonte S, Cipriani C (2015) The diagnosis and management of hypercalcaemia. BMJ 350:h2723. https:\/\/doi.org\/10.1136\/bmj.h2723","journal-title":"BMJ"},{"issue":"1","key":"3653_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2016.10.012","volume":"480","author":"A Movila","year":"2016","unstructured":"Movila A, Mawardi H, Nishimura K et al (2016) Possible pathogenic engagement of soluble Semaphorin 4D produced by \u03b3\u03b4T cells in medication-related osteonecrosis of the jaw (MRONJ). Biochem Biophys Res Commun 480(1):42\u201347. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.012","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3653_CR84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40001-023-01095-6","volume":"28","author":"H Mu","year":"2023","unstructured":"Mu H, Pang Y, Liu L, Liu J, Liu C (2023) Clinical values of serum Semaphorin 4D (Sema4D) in medication-related osteonecrosis of the jaw. Eur J Med Res 28(1):140. https:\/\/doi.org\/10.1186\/s40001-023-01095-6","journal-title":"Eur J Med Res"},{"issue":"2","key":"3653_CR85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s8756-3282(95)00150-6","volume":"17","author":"H Murakami","year":"1995","unstructured":"Murakami H, Takahashi N, Sasaki T et al (1995) A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17(2):137\u2013144. https:\/\/doi.org\/10.1016\/s8756-3282(95)00150-6","journal-title":"Bone"},{"issue":"10","key":"3653_CR86","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Hayashi M, Fukunaga T et al (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17(10):1231\u20131234. https:\/\/doi.org\/10.1038\/nm.2452","journal-title":"Nat Med"},{"issue":"2","key":"3653_CR87","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA et al (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127(2):117\u2013135. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"3653_CR88","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5125\/jkaoms.2021.47.2.65","volume":"47","author":"G Nifos\u00ec","year":"2021","unstructured":"Nifos\u00ec G, Nifos\u00ec L, Nifos\u00ec AF (2021) Mesenchymal stem cells in the treatment of osteonecrosis of the jaw. J Korean Assoc Oral Maxillofac Surg 47(2):65\u201375. https:\/\/doi.org\/10.5125\/jkaoms.2021.47.2.65","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"1","key":"3653_CR89","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5624\/isd.20200230","volume":"51","author":"I Ogura","year":"2021","unstructured":"Ogura I, Minami Y, Ono J et al (2021) CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw. Imaging Sci Dent 51(1):73\u201380. https:\/\/doi.org\/10.5624\/isd.20200230","journal-title":"Imaging Sci Dent"},{"issue":"3","key":"3653_CR90","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10266-016-0279-9","volume":"105","author":"Y Ohbayashi","year":"2017","unstructured":"Ohbayashi Y, Nakai F, Iwasaki A et al (2017) The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration. Odontology 105(3):382\u2013390. https:\/\/doi.org\/10.1007\/s10266-016-0279-9","journal-title":"Odontology"},{"issue":"1","key":"3653_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jdsr.2018.11.002","volume":"55","author":"Y Ohbayashi","year":"2019","unstructured":"Ohbayashi Y, Nakai F, Iwasaki A et al (2019) Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication). Jpn Dent Sci Rev 55(1):51\u201357. https:\/\/doi.org\/10.1016\/j.jdsr.2018.11.002","journal-title":"Jpn Dent Sci Rev"},{"key":"3653_CR92","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2147\/tcrm.S149236","volume":"14","author":"T Ohishi","year":"2018","unstructured":"Ohishi T, Matsuyama Y (2018) Minodronate for the treatment of osteoporosis. Ther Clin Risk Manag 14:729\u2013739. https:\/\/doi.org\/10.2147\/tcrm.S149236","journal-title":"Ther Clin Risk Manag"},{"key":"3653_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050680","author":"SW On","year":"2021","unstructured":"On SW, Cho SW, Byun SH, Yang BE (2021) Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches. Antioxidants (basel). https:\/\/doi.org\/10.3390\/antiox10050680","journal-title":"Antioxidants (basel)"},{"key":"3653_CR94","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.1038\/ncomms10928","volume":"7","author":"T Ono","year":"2016","unstructured":"Ono T, Okamoto K, Nakashima T et al (2016) IL-17-producing \u03b3\u03b4 T cells enhance bone regeneration. Nat Commun 7:10928. https:\/\/doi.org\/10.1038\/ncomms10928","journal-title":"Nat Commun"},{"key":"3653_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ctdb.2019.01.006","volume":"133","author":"N Ono","year":"2019","unstructured":"Ono N, Balani DH, Kronenberg HM (2019) Stem and progenitor cells in skeletal development. Curr Top Dev Biol 133:1\u201324. https:\/\/doi.org\/10.1016\/bs.ctdb.2019.01.006","journal-title":"Curr Top Dev Biol"},{"key":"3653_CR96","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K (2019) Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol 10:1084. https:\/\/doi.org\/10.3389\/fimmu.2019.01084","journal-title":"Front Immunol"},{"issue":"2","key":"3653_CR97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cyto.2008.05.010","volume":"43","author":"G Oteri","year":"2008","unstructured":"Oteri G, Allegra A, Bellomo G et al (2008) Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration. Cytokine 43(2):103\u2013104. https:\/\/doi.org\/10.1016\/j.cyto.2008.05.010","journal-title":"Cytokine"},{"issue":"2","key":"3653_CR98","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD (2009) Bisphosphonate-associated adverse Events. Hormones (athens) 8(2):96\u2013110. https:\/\/doi.org\/10.14310\/horm.2002.1226","journal-title":"Hormones (athens)"},{"issue":"5","key":"3653_CR99","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00784-020-03602-z","volume":"25","author":"P Paschalidi","year":"2021","unstructured":"Paschalidi P, Gkouveris I, Soundia A et al (2021) The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw. Clin Oral Investig 25(5):2845\u20132857. https:\/\/doi.org\/10.1007\/s00784-020-03602-z","journal-title":"Clin Oral Investig"},{"issue":"7","key":"3653_CR100","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/odi.12908","volume":"24","author":"S Patntirapong","year":"2018","unstructured":"Patntirapong S, Poolgesorn M (2018) Alteration of macrophage viability, differentiation, and function by bisphosphonates. Oral Dis 24(7):1294\u20131302. https:\/\/doi.org\/10.1111\/odi.12908","journal-title":"Oral Dis"},{"key":"3653_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2022.101648","volume":"18","author":"AB Pedersen","year":"2023","unstructured":"Pedersen AB, N\u00f8rholt SE, Rejnmark L, Langdahl B, Starch-Jensen T, S\u00f8rensen HT (2023) Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: a case-control study. Bone Rep 18:101648. https:\/\/doi.org\/10.1016\/j.bonr.2022.101648","journal-title":"Bone Rep"},{"issue":"6","key":"3653_CR102","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3174\/ajnr.A0518","volume":"28","author":"PM Phal","year":"2007","unstructured":"Phal PM, Myall RW, Assael LA, Weissman JL (2007) Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol 28(6):1139\u20131145. https:\/\/doi.org\/10.3174\/ajnr.A0518","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"3653_CR103","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jcms.2021.02.010","volume":"49","author":"RHM Preidl","year":"2021","unstructured":"Preidl RHM, Amann K, Weber M et al (2021) Lineage-associated connexin 43 expression in bisphosphonate-exposed rat bones. J Craniomaxillofac Surg 49(8):738\u2013747. https:\/\/doi.org\/10.1016\/j.jcms.2021.02.010","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"3653_CR104","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","volume":"22","author":"L Ramaglia","year":"2018","unstructured":"Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Investig 22(2):597\u2013615. https:\/\/doi.org\/10.1007\/s00784-017-2325-6","journal-title":"Clin Oral Investig"},{"issue":"6","key":"3653_CR105","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","volume":"16","author":"IR Reid","year":"2020","unstructured":"Reid IR (2020) A broader strategy for osteoporosis interventions. Nat Rev Endocrinol 16(6):333\u2013339. https:\/\/doi.org\/10.1038\/s41574-020-0339-7","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"3653_CR106","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/eje-22-0574","volume":"187","author":"IR Reid","year":"2022","unstructured":"Reid IR (2022) Extensive expertise in endocrinology: osteoporosis management. Eur J Endocrinol 187(4):R65-r80. https:\/\/doi.org\/10.1530\/eje-22-0574","journal-title":"Eur J Endocrinol"},{"key":"3653_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115390","volume":"137","author":"IR Reid","year":"2020","unstructured":"Reid IR, Green JR, Lyles KW et al (2020) Zoledronate. Bone 137:115390. https:\/\/doi.org\/10.1016\/j.bone.2020.115390","journal-title":"Bone"},{"issue":"5","key":"3653_CR108","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.joms.2013.11.005","volume":"72","author":"O Ristow","year":"2014","unstructured":"Ristow O, Gerngro\u00df C, Schwaiger M et al (2014) Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? J Oral Maxillofac Surg 72(5):903\u2013910. https:\/\/doi.org\/10.1016\/j.joms.2013.11.005","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"3653_CR109","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","volume":"47","author":"O Ristow","year":"2019","unstructured":"Ristow O, R\u00fcckschlo\u00df T, M\u00fcller M et al (2019) Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. J Craniomaxillofac Surg 47(3):491\u2013499. https:\/\/doi.org\/10.1016\/j.jcms.2018.12.014","journal-title":"J Craniomaxillofac Surg"},{"key":"3653_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097948","author":"I Roato","year":"2023","unstructured":"Roato I, Mauceri R, Notaro V, Genova T, Fusco V, Mussano F (2023) Immune dysfunction in medication-related osteonecrosis of the jaw. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24097948","journal-title":"Int J Mol Sci"},{"issue":"20","key":"3653_CR111","doi-asserted-by":"publisher","first-page":"6222s","DOI":"10.1158\/1078-0432.Ccr-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12(20):6222s\u20136230s. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0843","journal-title":"Clin Cancer Res"},{"issue":"27","key":"3653_CR112","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.2174\/138161210793563635","volume":"16","author":"AJ Roelofs","year":"2010","unstructured":"Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 16(27):2950\u20132960. https:\/\/doi.org\/10.2174\/138161210793563635","journal-title":"Curr Pharm Des"},{"issue":"2","key":"3653_CR113","doi-asserted-by":"publisher","first-page":"Cd008455","DOI":"10.1002\/14651858.CD008455.pub2","volume":"2","author":"V Rollason","year":"2016","unstructured":"Rollason V, Laverri\u00e8re A, MacDonald LC, Walsh T, Tram\u00e8r MR, Vogt-Ferrier NB (2016) Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev 2(2):Cd008455. https:\/\/doi.org\/10.1002\/14651858.CD008455.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3653_CR114","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"3653_CR115","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg 80(5):920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"3653_CR116","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733\u2013759. https:\/\/doi.org\/10.1007\/s00198-007-0540-8","journal-title":"Osteoporos Int"},{"key":"3653_CR117","doi-asserted-by":"publisher","first-page":"31604","DOI":"10.1038\/srep31604","volume":"6","author":"G Russmueller","year":"2016","unstructured":"Russmueller G, Seemann R, Weiss K et al (2016) The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Sci Rep 6:31604. https:\/\/doi.org\/10.1038\/srep31604","journal-title":"Sci Rep"},{"issue":"19","key":"3653_CR118","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","volume":"94","author":"F Saad","year":"2002","unstructured":"Saad F, Gleason DM, Murray R et al (2002) A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 94(19):1458\u20131468. https:\/\/doi.org\/10.1093\/jnci\/94.19.1458","journal-title":"J Natl Cancer Inst"},{"key":"3653_CR119","doi-asserted-by":"publisher","first-page":"9858921","DOI":"10.1155\/2018\/9858921","volume":"2018","author":"R Sacco","year":"2018","unstructured":"Sacco R, Sacco N, Hamid U, Ali SH, Singh M, Blythe JSJ (2018) Microsurgical reconstruction of the jaws using vascularised free flap technique in patients with medication-related osteonecrosis: a systematic review. Biomed Res Int 2018:9858921. https:\/\/doi.org\/10.1155\/2018\/9858921","journal-title":"Biomed Res Int"},{"issue":"1","key":"3653_CR120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bjoms.2019.09.023","volume":"58","author":"R Sacco","year":"2020","unstructured":"Sacco R, Shah S, Leeson R et al (2020) Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-\u03b1) inhibitors: a systematic review. Br J Oral Maxillofac Surg 58(1):25\u201333. https:\/\/doi.org\/10.1016\/j.bjoms.2019.09.023","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"5","key":"3653_CR121","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/medicina59050968","volume":"59","author":"R Sacco","year":"2023","unstructured":"Sacco R, Akintola O, Sacco N et al (2023) The use of human amniotic membrane (hAM) as a treatment strategy of medication-related osteonecrosis of the jaw (MRONJ): a systematic review and meta-analysis of the literature. Medicina (kaunas) 59(5):10. https:\/\/doi.org\/10.3390\/medicina59050968","journal-title":"Medicina (kaunas)"},{"issue":"10","key":"3653_CR122","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/annonc\/mdl163","volume":"17","author":"G Sanna","year":"2006","unstructured":"Sanna G, Preda L, Bruschini R et al (2006) Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Ann Oncol 17(10):1512\u20131516. https:\/\/doi.org\/10.1093\/annonc\/mdl163","journal-title":"Ann Oncol"},{"issue":"11","key":"3653_CR123","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1002\/jcb.23267","volume":"112","author":"EL Scheller","year":"2011","unstructured":"Scheller EL, Hankenson KD, Reuben JS, Krebsbach PH (2011) Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production. J Cell Biochem 112(11):3364\u20133372. https:\/\/doi.org\/10.1002\/jcb.23267","journal-title":"J Cell Biochem"},{"issue":"3","key":"3653_CR124","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.joms.2006.10.043","volume":"65","author":"FC Senel","year":"2007","unstructured":"Senel FC, Saracoglu Tekin U, Durmus A, Bagis B (2007) Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case. J Oral Maxillofac Surg 65(3):562\u2013565. https:\/\/doi.org\/10.1016\/j.joms.2006.10.043","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"3653_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1\u201323. https:\/\/doi.org\/10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"issue":"9","key":"3653_CR126","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429","journal-title":"J Cell Physiol"},{"issue":"12","key":"3653_CR127","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.stem.2021.08.010","volume":"28","author":"HS Shu","year":"2021","unstructured":"Shu HS, Liu YL, Tang XT et al (2021) Tracing the skeletal progenitor transition during postnatal bone formation. Cell Stem Cell 28(12):2122-2136.e3. https:\/\/doi.org\/10.1016\/j.stem.2021.08.010","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3653_CR128","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2016.7403","volume":"7","author":"FM Silveira","year":"2016","unstructured":"Silveira FM, Etges A, Correa MB, Vasconcelos AC (2016) Microscopic evaluation of the effect of oral microbiota on the development of bisphosphonate-related osteonecrosis of the jaws in rats. J Oral Maxillofac Res 7(4):e3. https:\/\/doi.org\/10.5037\/jomr.2016.7403","journal-title":"J Oral Maxillofac Res"},{"issue":"26","key":"3653_CR129","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/jco.19.02192","volume":"38","author":"IW Sim","year":"2020","unstructured":"Sim IW, Borromeo GL, Tsao C et al (2020) Teriparatide Promotes Bone Healing In Medication-Related Osteonecrosis Of The Jaw: A Placebo-Controlled. Randomized Trial J Clin Oncol 38(26):2971\u20132980. https:\/\/doi.org\/10.1200\/jco.19.02192","journal-title":"Randomized Trial J Clin Oncol"},{"issue":"2","key":"3653_CR130","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC (2009) Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 45(2):164\u2013172. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.04.013","journal-title":"Oral Oncol"},{"issue":"7","key":"3653_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201343","volume":"13","author":"S Soutome","year":"2018","unstructured":"Soutome S, Hayashida S, Funahara M et al (2018) Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor? PLoS ONE 13(7):e0201343. https:\/\/doi.org\/10.1371\/journal.pone.0201343","journal-title":"PLoS ONE"},{"issue":"1","key":"3653_CR132","doi-asserted-by":"publisher","first-page":"17226","DOI":"10.1038\/s41598-021-96480-8","volume":"11","author":"S Soutome","year":"2021","unstructured":"Soutome S, Otsuru M, Hayashida S et al (2021) Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients. Sci Rep 11(1):17226. https:\/\/doi.org\/10.1038\/s41598-021-96480-8","journal-title":"Sci Rep"},{"issue":"5","key":"3653_CR133","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1601-0825.2007.01402.x","volume":"14","author":"D Stefanik","year":"2008","unstructured":"Stefanik D, Sarin J, Lam T, Levin L, Leboy PS, Akintoye SO (2008) Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate. Oral Dis 14(5):465\u2013471. https:\/\/doi.org\/10.1111\/j.1601-0825.2007.01402.x","journal-title":"Oral Dis"},{"issue":"1","key":"3653_CR134","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176(1):287\u2013292. https:\/\/doi.org\/10.1084\/jem.176.1.287","journal-title":"J Exp Med"},{"issue":"3","key":"3653_CR135","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00784-009-0293-1","volume":"14","author":"P Stockmann","year":"2010","unstructured":"Stockmann P, Hinkmann FM, Lell MM et al (2010) Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig 14(3):311\u2013317. https:\/\/doi.org\/10.1007\/s00784-009-0293-1","journal-title":"Clin Oral Investig"},{"issue":"1","key":"3653_CR136","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12903-021-01634-9","volume":"21","author":"B Ta\u015f Ozyurtseven","year":"2021","unstructured":"Ta\u015f Ozyurtseven B, Serin I, Nursal AF, Pehlivan S, Pehlivan M (2021) Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience. BMC Oral Health 21(1):272. https:\/\/doi.org\/10.1186\/s12903-021-01634-9","journal-title":"BMC Oral Health"},{"issue":"5","key":"3653_CR137","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1124\/mol.105.020776","volume":"69","author":"K Thompson","year":"2006","unstructured":"Thompson K, Rogers MJ, Coxon FP, Crockett JC (2006) Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol 69(5):1624\u20131632. https:\/\/doi.org\/10.1124\/mol.105.020776","journal-title":"Mol Pharmacol"},{"issue":"1","key":"3653_CR138","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41598-018-37063-y","volume":"9","author":"LF Toro","year":"2019","unstructured":"Toro LF, de Mello-Neto JM, Santos F et al (2019) Application of autologous platelet-rich plasma on tooth extraction site prevents occurence of medication-related osteonecrosis of the jaws in rats. Sci Rep 9(1):22. https:\/\/doi.org\/10.1038\/s41598-018-37063-y","journal-title":"Sci Rep"},{"issue":"5","key":"3653_CR139","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.oooo.2015.02.005","volume":"119","author":"SR Torres","year":"2015","unstructured":"Torres SR, Chen CS, Leroux BG et al (2015) Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol 119(5):584\u2013592. https:\/\/doi.org\/10.1016\/j.oooo.2015.02.005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"12","key":"3653_CR140","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/jbmr.5650091206","volume":"9","author":"E van Beek","year":"1994","unstructured":"van Beek E, Hoekstra M, van de Ruit M, L\u00f6wik C, Papapoulos S (1994) Structural requirements for bisphosphonate actions in vitro. J Bone Miner Res 9(12):1875\u20131882. https:\/\/doi.org\/10.1002\/jbmr.5650091206","journal-title":"J Bone Miner Res"},{"issue":"35","key":"3653_CR141","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/jco.2017.75.4614","volume":"35","author":"C Van Poznak","year":"2017","unstructured":"Van Poznak C, Somerfield MR, Barlow WE et al (2017) Role of bone-modifying agents in metastatic breast cancer: an american society of clinical oncology-cancer care ontario focused guideline update. J Clin Oncol 35(35):3978\u20133986. https:\/\/doi.org\/10.1200\/jco.2017.75.4614","journal-title":"J Clin Oncol"},{"issue":"4","key":"3653_CR142","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4081\/reumatismo.2013.143","volume":"65","author":"M Varenna","year":"2013","unstructured":"Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M (2013) Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature. Reumatismo 65(4):143\u2013166. https:\/\/doi.org\/10.4081\/reumatismo.2013.143","journal-title":"Reumatismo"},{"issue":"8","key":"3653_CR143","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.amjcard.2007.12.013","volume":"101","author":"R Varma","year":"2008","unstructured":"Varma R, Aronow WS, Basis Y et al (2008) Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 101(8):1103\u20131104. https:\/\/doi.org\/10.1016\/j.amjcard.2007.12.013","journal-title":"Am J Cardiol"},{"issue":"3","key":"3653_CR144","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","volume":"291","author":"V Viereck","year":"2002","unstructured":"Viereck V, Emons G, Lauck V et al (2002) Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291(3):680\u2013686. https:\/\/doi.org\/10.1006\/bbrc.2002.6510","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3653_CR145","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/CAD.0b013e328360335f","volume":"24","author":"E Vrdoljak","year":"2013","unstructured":"Vrdoljak E, Rini B, Schmidinger M et al (2013) Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone. Anticancer Drugs 24(5):431\u2013440. https:\/\/doi.org\/10.1097\/CAD.0b013e328360335f","journal-title":"Anticancer Drugs"},{"issue":"1","key":"3653_CR146","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1056\/NEJMoa0802633","volume":"360","author":"RS Weinstein","year":"2009","unstructured":"Weinstein RS, Roberson PK, Manolagas SC (2009) Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360(1):53\u201362. https:\/\/doi.org\/10.1056\/NEJMoa0802633","journal-title":"N Engl J Med"},{"issue":"2","key":"3653_CR147","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","volume":"111","author":"F Wilde","year":"2011","unstructured":"Wilde F, Heufelder M, Winter K et al (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153\u2013163. https:\/\/doi.org\/10.1016\/j.tripleo.2010.04.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"3653_CR148","doi-asserted-by":"publisher","first-page":"289","DOI":"10.11607\/prd.2751","volume":"38","author":"JP Woelber","year":"2018","unstructured":"Woelber JP, Fleiner J, Rau J, Ratka-Kr\u00fcger P, Hannig C (2018) Accuracy and usefulness of CBCT in periodontology: a systematic review of the literature. Int J Periodontics Restorative Dent 38(2):289\u2013297. https:\/\/doi.org\/10.11607\/prd.2751","journal-title":"Int J Periodontics Restorative Dent"},{"issue":"3","key":"3653_CR149","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S et al (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302(3):1055\u20131061. https:\/\/doi.org\/10.1124\/jpet.102.035295","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"3653_CR150","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O\u2019Brien CA (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17(10):1235\u20131241. https:\/\/doi.org\/10.1038\/nm.2448","journal-title":"Nat Med"},{"issue":"8","key":"3653_CR151","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/RLU.0b013e3181e4df11","volume":"35","author":"Y Yamazaki","year":"2010","unstructured":"Yamazaki Y, Kitagawa Y, Hata H et al (2010) Use of FDG PET to evaluate hyperbaric oxygen therapy for bisphosphonate-related osteonecrosis of the jaw. Clin Nucl Med 35(8):590\u2013591. https:\/\/doi.org\/10.1097\/RLU.0b013e3181e4df11","journal-title":"Clin Nucl Med"},{"issue":"6","key":"3653_CR152","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00520-020-05355-7","volume":"28","author":"M Yang","year":"2020","unstructured":"Yang M, Yu X (2020) Management of bone metastasis with intravenous bisphosphonates in breast cancer: a systematic review and meta-analysis of dosing frequency. Support Care Cancer 28(6):2533\u20132540. https:\/\/doi.org\/10.1007\/s00520-020-05355-7","journal-title":"Support Care Cancer"},{"key":"3653_CR153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bone.2019.04.010","volume":"124","author":"G Yang","year":"2019","unstructured":"Yang G, Singh S, Chen Y et al (2019) Pharmacogenomics of osteonecrosis of the jaw. Bone 124:75\u201382. https:\/\/doi.org\/10.1016\/j.bone.2019.04.010","journal-title":"Bone"},{"issue":"25","key":"3653_CR154","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/jco.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE et al (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol 37(25):2270\u20132290. https:\/\/doi.org\/10.1200\/jco.19.01186","journal-title":"J Clin Oncol"},{"issue":"9","key":"3653_CR155","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jcms.2019.06.004","volume":"47","author":"A Yuan","year":"2019","unstructured":"Yuan A, Munz A, Reinert S, Hoefert S (2019) Gingival fibroblasts and medication-related osteonecrosis of the jaw: results by real-time and wound healing in vitro assays. J Craniomaxillofac Surg 47(9):1464\u20131474. https:\/\/doi.org\/10.1016\/j.jcms.2019.06.004","journal-title":"J Craniomaxillofac Surg"},{"issue":"12","key":"3653_CR156","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1158\/1078-0432.Ccr-13-0042","volume":"19","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Atsuta I, Liu S et al (2013) IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res 19(12):3176\u20133188. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-0042","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3653_CR157","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12903-022-02678-1","volume":"23","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Dong X, Chen S et al (2023) Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing. BMC Oral Health 23(1):14. https:\/\/doi.org\/10.1186\/s12903-022-02678-1","journal-title":"BMC Oral Health"},{"issue":"4","key":"3653_CR158","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.201801791RR","volume":"33","author":"W Zhu","year":"2019","unstructured":"Zhu W, Xu R, Du J et al (2019) Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw. Faseb j 33(4):5208\u20135219. https:\/\/doi.org\/10.1096\/fj.201801791RR","journal-title":"Faseb j"},{"issue":"3","key":"3653_CR159","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.oraloncology.2010.12.003","volume":"47","author":"T Ziebart","year":"2011","unstructured":"Ziebart T, Koch F, Klein MO et al (2011) Geranylgeraniol\u2014a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw. Oral Oncol 47(3):195\u2013201. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.12.003","journal-title":"Oral Oncol"},{"issue":"5","key":"3653_CR160","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00784-018-2655-z","volume":"23","author":"M Zirk","year":"2019","unstructured":"Zirk M, Wenzel C, Buller J, Z\u00f6ller JE, Zinser M, Peters F (2019) Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw. Clin Oral Investig 23(5):2143\u20132151. https:\/\/doi.org\/10.1007\/s00784-018-2655-z","journal-title":"Clin Oral Investig"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03653-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:11:47Z","timestamp":1708013507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03653-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No potential ethical issues were disclosed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}